Product peptide-synthetic-peptide

Home > products > peptide> synthetic-peptide

Catalog	name	Description	price
R-M-1034	(D-Trp¹¹)-Neurotensin acetate salt	(D-Trp¹¹)-Neurotensin acetate salt,CAS:100929-52-0 from ruixi.It is a synthetic peptide. Ruixi can provide a variety of customized peptides.	price>
R-M-1035	Neurotensin (1-8)	Neurotensin (1-8) ,CAS :80887-44-1 from ruixi.It is a synthetic peptide. Ruixi can provide a variety of customized peptides.	price>
R-M-1036	Neurotensin (8-13) acetate salt,CAS : 60482-95-3	Neurotensin (8-13) acetate salt,CAS : 60482-95-3 from ruixi.Its sequence is RRPYIL.The sequence RRPYIL is essential for neurotensin-NT receptor interaction.	price>
R-M-1039	Acetyl-Neurotensin (8-13),CAS : 74853-69-3	The truncated sequence Ac-RRPYIL is the shortest neurotensin analog with full binding and pharmacological activities.	price>
R-M-1022	Nociceptin (1-13) amide trifluoroacetate salt,CAS : 178064-02-3	This agonist of nociceptin is the smallest peptide maintaining the same efficacy and potency as the natural peptide. The amidation protects it from degradation by proteases.	price>
R-M-1023	Nocistatin (bovine) trifluoroacetate salt,CAS :208253-85-4	Nocistatin is generated from the same precursor as the neuropeptide nociceptin, an endogenous ligand for the orphan opioid-like receptor. The opposite roles of nociceptin and nocistatin in pain transmission have been described. This compound may lead to the design of analgesics devoid of the addiction and dependence associated with morphine.	price>
R-M-1025	Obestatin (human) trifluoroacetate salt,CAS:1081110-72-6	Obestatin (human) trifluoroacetate salt,CAS:1081110-72-6 from ruixi.It can be applied to gastrointestinal research, obsity research.	price>
R-M-1032	(Lys(Ac)⁵)-Octreotide acetate salt,CAS:173606-11-6	(Lys(Ac)⁵)-Octreotide acetate salt ,CAS:173606-11-6 from ruixi.It can be applied to cancer research.	price>
R-M-1043	Orexin A (1-15) (free acid) trifluoroacetate salt,CAS:2022956-49-4	Orexin A (1-15) (free acid) trifluoroacetate salt,CAS:2022956-49-4 from ruixi.N-terminal segment of orexin A containing both disulfide bridges.	price>
R-M-1045	orexin-a-17-33-trifluoroacetate-salt,CAS: 343268-91-7	Orexin A (17-33) acts as selective OX1 antagonist. Truncation studies have led to OXA (17-33) as the shortest active peptide known to date with a 23-fold selectivity for OX1 over OX2. The native orexins A and B do not show distinct receptor selectivity. Both OX receptors are involved in energy homeostasis and the sleep/wake cycle, hence selective as well as dual antagonists are required for research.	price>

...